Evaluation of POC Lung Ultrasound Combined With Pressure-volume Curve to Titration Adjust PEEP for ARDS Lung Recruitment

NCT ID: NCT03076450

Last Updated: 2017-05-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-01

Study Completion Date

2018-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Using lung ultrasound re-aeration score(LUS-RAS) combined with pressure-volume curve(PVC) adjust maintain positive end-expiratory pressure(PEEP) after recruitment maneuver, to achieve real-time adjustment, reduce ventilation-associated lung injury and the purpose of effective lung recruitment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The traditional method, set PEEP according to PVC in ARDS mechanical ventilation, lacks morphological evaluation. For point-of-care lung ultrasound(POC-LUS) is non-invasive, real-time, visualization, no need transport patients, getting more and more attention in the ARDS treatment. It has been reported that LUS-RAS is a meaningful assessment in recruitment maneuver. This study will combine POC-LUS with PVC in set the initial peep, and then dynamic record LUS-RAS to feedback regulate PEEP. Using the POC-LUS and maximum oxygenation method to assess lung recruitment effect in experimental group and control group prospectively. The ventilator parameters, state of hemodynamic, arterial blood gas(ABG) in each group will be recorded; Statistical methods will be performed in term to understand the correlation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Maximum Oxygenation

Using PVC to set the initial peep, check ABG real-time, and according to PaO2+PaCO2≥400mmHg whether or not to adjust maintain PEEP.

Group Type ACTIVE_COMPARATOR

Maximum Oxygenation

Intervention Type DIAGNOSTIC_TEST

Adjust PEEP real-time in term of PaO2+PaCO2≥400mmHg whether or not.

Lung Ultrasound Re-aeration Score

Combine POC-LUS with PVC in set the initial peep, and then dynamic record LUS-RAS to feedback regulate PEEP.

Group Type EXPERIMENTAL

Lung Ultrasound

Intervention Type DEVICE

Adjust PEEP real-time in term of LUS-RAS chang.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lung Ultrasound

Adjust PEEP real-time in term of LUS-RAS chang.

Intervention Type DEVICE

Maximum Oxygenation

Adjust PEEP real-time in term of PaO2+PaCO2≥400mmHg whether or not.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patient aged 18 years and older
* ARDS patients with invasive mechanical ventilation

Exclusion Criteria

* Intracranial hypertension
* Pneumothorax and mediastinal emphysema
* Severe hypoxemia (oxygenation index \<100)
* Hemodynamic instability
* Chest deformity or surgical history
* Affect Lung-ultrasound conditions: subcutaneous emphysema, chest wound etc.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Municipal Commission of Health and Family Planning

OTHER

Sponsor Role collaborator

Shanghai Pudong New Area Gongli Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Qiancheng Luo

Attending-doctor of Critical Care Medcine, Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Qiancheng Luo, MM

Role: PRINCIPAL_INVESTIGATOR

Shanghai Pudong New Area Gongli Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gongli Hospital

Pudong, Shanghai Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Qiancheng Luo, MM

Role: CONTACT

008613564781737

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Qiancheng Luo, MM

Role: primary

008613564781737

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201640405

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Trans-pulmonary Pressure in ARDS
NCT02416037 COMPLETED NA